A Randomized Phase III Study of Combination Antineoplaston Therapy [Antineoplaston A10 (Atengenat) and AS2-1 (Astugenal)] Plus Radiation Therapy vs. Radiation Therapy Alone in Subjects with Newly Diagnosed, Diffuse, Intrinsic Brain Stem Glioma

Trial Profile

A Randomized Phase III Study of Combination Antineoplaston Therapy [Antineoplaston A10 (Atengenat) and AS2-1 (Astugenal)] Plus Radiation Therapy vs. Radiation Therapy Alone in Subjects with Newly Diagnosed, Diffuse, Intrinsic Brain Stem Glioma

Recruiting
Phase of Trial: Phase III

Latest Information Update: 23 Jun 2014

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top